New CKM guideline urges team-based care, yet UH data show major therapy gaps; CINEMA model boosts outcomes amid cost, trust, and handoff hurdles.
|Articles|July 1, 1999
Supplements and Featured Publications
- Evaluating the Health Benefits of Atypical Agents in the Treatment and Management of Psychoses
- Volume 5
- Issue 10 Suppl
Introduction
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Assessment of Quality-of-Life Outcomes in Schizophrenic Patientsabout 27 years ago
The Emerging Role of Psychiatric Pharmacistsabout 27 years ago
CME/CE Quizabout 27 years ago
Selected Abstractsabout 27 years ago
BibliographyAdvertisement
Related to this article
Obesity care surges with GLP-1 demand, but fragmented ownership, prior authorizations, and coverage rules stall treatment—pharmacists step in.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant Plus Abemaciclib for Breast Cancer
2
Higher CPAP Adherence Linked With Lower Mortality Risk in OSA
3
Lung Cancer Progress Drives Down US Cancer Death Rates
4
FDA Approves First Treatment for Sanfilippo Syndrome Type A
5